FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

F.H. INVESTMENTS, Inc. (dba Asteria Health) Estradiol Recall

ESTRADIOL, 37

F.H. INVESTMENTS, Inc. (dba Asteria Health) · Birmingham, AL

Risk level
Class II
Reported by FDA
Feb 18, 2026
Recall ID
D-0315-2026
Check your lot numberHow we source this data

Summary

F.H. INVESTMENTS, Inc. (dba Asteria Health) recalled Estradiol starting Jan 26, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0315-2026 on Feb 18, 2026. Reason: Presence of Foreign substance - potential presence of metal particulate matter. Status: Ongoing.

Why it was recalled

Presence of Foreign substance - potential presence of metal particulate matter

Product description

ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.

Lot numbers, UPCs & expiration codes

Lot#: 253000125, Exp. 06/09/2026.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0315-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 26, 2026
FDA report date
Feb 18, 2026
Quantity
715 pellets
Recall type
Voluntary: Firm initiated
Recalling firm
F.H. INVESTMENTS, Inc. (dba Asteria Health)

Original FDA data

Every field from FDA enforcement report D-0315-2026, exactly as published.

Show all FDA fields
City
Birmingham
State
AL
Status
Ongoing
Country
United States
Event ID
98344
Address
432 Industrial Ln
Code information
Lot#: 253000125, Exp. 06/09/2026.
Postal code
35211-4465
Report date
Feb 18, 2026
Product type
Drugs
Recall number
D-0315-2026
Classification
Class II
Recalling firm
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Product quantity
715 pellets
Reason for recall
Presence of Foreign substance - potential presence of metal particulate matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 26, 2026
Initial firm notification
Letter
Center classification date
Feb 11, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0315-2026, published Feb 18, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls